LATAM MedTech Insights

Brazil's regulatory agency, ANVISA, is updating its rules for Software as a Medical Device (SaMD) as a key priority for 2025. This major overhaul will align Brazil’s digital health landscape with global standards like the EU MDR, introducing stricter requirements for cybersecurity, interoperability, and technical documentation. This change presents a critical challenge for MedTech innovators. For...

Last week, Brazil's ANVISA implemented a sudden and strict new regulation for cybersecurity in connected medical devices. This unexpected move introduces mandatory data localization, forcing companies to store Brazilian patient data on servers within the country, creating significant technical and financial hurdles for global manufacturers. This episode of LATAM MedTech Insights unpacks the immedi...

Brazil's regulatory agency, ANVISA, has just redefined the future of digital health in Latin America with its new, comprehensive framework for AI-powered Software as a Medical Device (SaMD). This landmark regulation introduces a stricter risk classification system and new requirements for algorithm validation and cybersecurity, directly impacting any MedTech company looking to enter or grow in the...

This week on LATAM MedTech Insights, we're diving into a groundbreaking regulatory shift in Brazil. For years, launching a clinical trial in Latin America's largest market was a high-risk gamble due to unpredictable and lengthy approval processes. Now, everything has changed. A new Clinical Research Statute is dismantling these old barriers, aiming to slash approval times and make Brazil a global...

This episode of LATAM MedTech Insights dives deep into the most significant regulatory shift in the region's largest market: Brazil. We explore ANVISA's new regulations, RDC 751/2022 for medical devices and RDC 830/2023 for IVDs, which align Brazil's framework more closely with international standards like the EU MDR. This is a critical update for any MedTech company looking to enter or expand its...

In this episode of LATAM MedTech Insights, we explore why a one-size-fits-all approach to entering the Latin American medical technology market is a recipe for failure. The region is not a monolith but a collection of unique countries, each with its own distinct regulatory, economic, and healthcare systems. Success depends on moving beyond surface-level data and leveraging deep market intelligence...

Brazil's MedTech market offers immense opportunity, but its regulatory body, ANVISA, demands flawless execution. A fragmented approach, where different teams handle registration and post-market compliance, often leads to costly delays and strategic dead ends. This episode explores why an integrated strategy is non-negotiable for success. We break down the four pillars of Brazilian MedTech regulati...

In this episode of LATAM MedTech Insights, we dive deep into the unique regulatory landscape of Colombia, a pivotal market for any device manufacturer looking to enter Latin America. We uncover how INVIMA's dual-track system offers a strategic gateway for MedTech companies that know how to leverage it. We explore the powerful "automatic registration" pathway for low-risk devices that can get your...

In this episode of LATAM MedTech Insights, we demystify the complex process of medical device registration in Argentina. We provide a detailed guide on navigating the requirements of the national regulatory authority, ANMAT, from appointing a local registration holder to preparing a compliant technical dossier in Spanish. We break down the critical steps and common pitfalls that can lead to costly...

Peru's MedTech market offers immense growth opportunities, but entry is strictly controlled by its regulatory authority, DIGEMID. A critical step for any foreign manufacturer is appointing a local representative, known as a Peru Registration Holder. This isn't just a formality—it's a foundational strategic decision that dictates your control over your own products in the country. In this episode,...

This episode of LATAM MedTech Insights dives into one of the most stable and attractive regulatory environments in Latin America: Colombia. We explore how INVIMA, the national regulatory authority, offers a clear and predictable pathway for medical device manufacturers, standing in contrast to the complexities found elsewhere in the region. We specifically focus on the significant strategic advant...

Brazil, Latin America's largest MedTech market, is implementing a mandatory Unique Device Identification (UDI) system, with a critical deadline for high-risk devices looming in mid-2025. This change, mandated by ANVISA's RDC 591/2021, requires immediate action from manufacturers to ensure their products remain on the market. This episode of LATAM MedTech Insights breaks down the essential steps fo...

In this episode of LATAM MedTech Insights, we demystify the complex world of Brazil's medical device regulations under ANVISA. We explore the critical differences between the faster 'Notificação' pathway for low-risk devices and the intensive 'Registro' full-review process for high-risk products, revealing why your strategy for one won't work for the other. This episode is for any MedTech company...

In this episode of LATAM MedTech Insights, we explore the groundbreaking regulatory reforms in Mexico that are set to accelerate market access for medical device manufacturers. We break down the new COFEPRIS abbreviated pathway, which leverages approvals from other international regulatory bodies to streamline the registration process. This shift marks a significant opportunity for MedTech and IVD...

Mexico presents a golden opportunity for MedTech companies, but its regulatory body, COFEPRIS, has a critical requirement: all foreign manufacturers must appoint a local Mexico Registration Holder (MRH). This entity doesn't just submit your paperwork; they legally own your product registration, a detail that can make or break your business in the region. This episode of LATAM MedTech Insights dive...

In this episode of LATAM MedTech Insights, we dissect the complex regulatory pathways for two key medical device categories in Latin America: surgical instrument sets and electrosurgical units. We explore the fragmented nature of LATAM regulations, moving beyond generalities to offer specific, actionable insights. We delve into the critical "family grouping" strategies required by Brazil's ANVISA...

The Latin American market for anesthesia machines and equipment is expanding rapidly, driven by significant investments in both public and private healthcare infrastructure. This growth presents a massive opportunity for MedTech manufacturers, but it comes with a formidable challenge: a highly complex and fragmented regulatory environment that can stop even the most prepared companies in their tra...

In this episode of LATAM MedTech Insights, we explore the immense opportunities and significant regulatory challenges of bringing blood glucose monitoring devices to the Latin American market. We uncover the specific demands of key regulatory bodies like Brazil's ANVISA, Mexico's COFEPRIS, and Argentina's ANMAT. We break down the complex, country-specific requirements that often trip up manufactur...

In this episode of LATAM MedTech Insights, we delve into the booming orthopedic surgical implant market across Latin America. We uncover why a successful market-entry strategy requires more than just a great product and existing international approvals. We explore the complex and fragmented regulatory landscapes of key countries like Brazil, Mexico, and Colombia, highlighting the critical differen...

In this episode of LATAM MedTech Insights, we delve into the rapidly expanding but notoriously complex market for cardiac monitoring and ECG devices in Latin America. We uncover why the region's high demand, fueled by demographic shifts and a growing healthcare sector in countries like Brazil, Mexico, and Argentina, presents both a massive opportunity and a significant challenge for global MedTech...

In this episode of LATAM MedTech Insights, we delve into the burgeoning market for digital X-ray and radiographic equipment in Latin America. We explore the powerful growth drivers, from government healthcare modernization projects in Brazil to the booming private medical sector in Mexico, revealing why this region is a key target for global MedTech innovators. However, this opportunity is guarded...

In this episode of LATAM MedTech Insights, we dissect the burgeoning market for endoscopic imaging systems in Latin America. We explore the massive opportunities in key countries and expose the intricate regulatory hurdles that often lead to costly delays and market access failures for international MedTech companies. We move beyond theory to discuss the practical realities of registering advanced...

In this episode of LATAM MedTech Insights, we explore the lucrative yet complex market for infusion pumps in Latin America. As hospitals across the region upgrade their technology for better patient outcomes, the demand for advanced medication delivery systems is at an all-time high. However, gaining market access is a formidable challenge, with each country's regulatory agency—from Brazil's ANVIS...

In this episode of LATAM MedTech Insights, we move beyond the headlines of the pandemic to uncover the real state of the respiratory device market in Latin America. The urgent rush for ventilators has subsided, leaving behind a complex landscape of equipment surplus, shifting clinical needs, and formidable regulatory barriers. We explore how the focus is moving from emergency ICU equipment to long...

In this episode of LATAM MedTech Insights, we explore the rapidly growing but complex market for hemodialysis machines and dialyzers in Latin America. We uncover the key drivers behind the region's multi-billion dollar renal care industry, focusing on the specific regulatory, logistical, and commercial hurdles in key countries like Brazil, Mexico, and Colombia. We examine real-world scenarios wher...